P. Gaulard

Discipline

Economies et finances (6) Histoire, Philosophie et Sociologie des sciences (2) Sociologie (1) Linguistique (1)

Type de document

Articles (32) Recensions (5)

Co-auteur

Date

Source

Mot-clé

Lymphomas (28) Human beings (16) Cells (12) Patients (11) Patients (11) Treatment (9) Cases (8) Expression (8) Cases (8) maladie (7) T cells (7) Mice (7) Example (7) maladie (7) thérapie (6) gène (6) survie (6) Tumors (6) Therapeutics (6) Survival (6) protéine (5) classification (5) Diseases (5) Genes (5) Impact (5) Genetic regulation (5) Diseases (5) Classification (5) Addition (5) Classification (5)

Documents écrit par P. Gaulard (32) | parle de P. Gaulard (0)

Angioimmunoblastic T-cell lymphoma and Kaposi sarcoma: A fortuitous collision?
E. Poullot et al.
KIR3DL2 may represent a novel therapeutic target in aggressive systemic peripheral T-cell lymphoma.
A. Decroos et al. (1 oct. 2023)
IDH2 and TET2 mutations synergize to modulate T Follicular Helper cell functional interaction with the AITL microenvironment.
J. Leca et al. (13 févr. 2023)
Monomorphic epitheliotropic intestinal T-cell lymphoma comprises morphologic and genomic heterogeneity impacting outcome.
L. Veloza et al. (1 janv. 2023)
Extranodal T- and NK-cell lymphomas.
L. de Leval et al.
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee.
E. Campo et al. (15 sept. 2022)
The EHA Research Roadmap: Malignant Lymphoid Diseases.
M. Dreyling et al.
Prolonged Remissions After Nivolumab Plus Gemcitabine/Oxaliplatin in Relapsed/Refractory T-cell Lymphoma.
R. Houot et al.
Super-enhancer-based identification of a BATF3/IL-2R-module reveals vulnerabilities in anaplastic large cell lymphoma.
H.C. Liang et al. (22 sept. 2021)
Chronic T cell receptor stimulation unmasks NK receptor signaling in peripheral T cell lymphomas via epigenetic reprogramming.
S. Carras et al. (1 juil. 2021)
Fusion transcripts FYN-TRAF3IP2 and KHDRBS1-LCK hijack T cell receptor signaling in peripheral T-cell lymphoma, not otherwise specified.
K. Debackere et al. (17 juin 2021)
Integrative analysis of a phase 2 trial combining lenalidomide with CHOP in angioimmunoblastic T-cell lymphoma.
F. Lemonnier et al. (26 janv. 2021)
Controversies in the Treatment of Peripheral T-cell Lymphoma.
E. Bachy et al.
The Need for a Consensus Next-generation Sequencing Panel for Mature Lymphoid Malignancies
P. Sujobert et al.
New insights in the pathogenesis of T-cell lymphomas.
F. Lemonnier et al.
RNA fusions involving CD28 are rare in peripheral T-cell lymphomas and concentrate mainly in those derived from follicular helper T cells.
D. Vallois et al.
Loss of 5-hydroxymethylcytosine is a frequent event in peripheral T-cell lymphomas.
F. Lemonnier et al.
Du neuf dans l’oncogenèse moléculaire des lymphomes : rôle du gène SETD2 dans les lymphomes T de l’intestin [Molecular oncogenesis of lymphomas: role of the SETD2 gene in intestinal T-cell lymphomas]
D. Vallois et al.
Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin.
M.P. Dobay et al.
The IDH2 R172K mutation associated with angioimmunoblastic T-cell lymphoma produces 2HG in T cells and impacts lymphoid development.
F. Lemonnier et al. (27 déc. 2016)
Type II enteropathy-associated T-cell lymphoma features a unique genomic profile with highly recurrent SETD2 alterations.
A. Roberti et al. (2016)
Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas.
D. Vallois et al. (2016)
Angioimmunoblastic T-cell lymphoma is the most common T-cell lymphoma in two distinct French information data sets.
L. de Leval et al. (2015)
Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells.
C. Küçük et al. (2015)
Immunohistochemistry as a valuable tool to assess CD30 expression in peripheral T-cell lymphomas: high correlation with mRNA levels.
C. Bossard et al. (6 nov. 2014)

next